|
|
Portfolio Company News
|
|
Accelerator Corporation is building the next generation of life-enhancing biotechnology companies by providing the resources critical to accelerating the development of nascent leading-edge biotechnologies. Chad Waite is on the board.
|
|
Portfolio Company News
|
|
Headquartered in Seattle, Washington, Adapx (pronounced Adapts) is transforming the way users interact with technology by innovating human-centered technology that improves the mobility, simplicity, accuracy, speed, reliability and intelligibility of information capture and communication. Chad Waite is on the board.
- With defense work growing, Adapx secures $3 million - Geekwire, January 23, 2012
- Adapx Announces New Contract Award with US Army RDECOM - citybizlist.com, October 10, 2011
- Adapx links digital pen technologies with SharePoint - GeekWire, October 3, 2011
- Digital pen software maker Adapx inks $5 million round - GeekWire, May 20, 2011
- Energy Transfer Automates Pipeline Inspections with Capturx, Directions Magazine - February 14, 2011
- Adapx Announces New Oil & Gas Customers and Tech Showcase at 2011 Microsoft Global Energy Forum, Directons Magazine - January 20, 2011
- Adapx raises $2M - TechFlash, January 12, 2011
- Capturx Streamlines Energy Audits by 33% - Sys-Con Media, December 7, 2010
- Former Microsoft vice president joins board of Adapx - TechFlash, October 12, 2010
- A short CapturX demo - July 19, 2010
- Adapx Showcases new CapturX Cloud Services for SharePoint, April 20, 2010
- Adapx to Provide Natural User Interface Tech to BAE Systems, Trading Markets - March 3, 2010
- "coolest thing at the show" - SPTechReport, February 11, 2010
|
|
Portfolio Company News
|
|
Aggregate Knowledge has an analytics platform for audience optimization and personalization. Lucinda Stewart is on the board.
- Aggregate Knowledge Names Former Adobe Exec, Douglas Grounds, as Sr. VP, Customer Success - October 19, 2011
- Automating Audience Mangement with Aggregate Knowledge - adotas, July 20, 2010
- Aggregate Knowledge names new CEO - Business Journal, May 4, 2010
- Aggregate Knowledge and BlueKai form Strategic Alliance, BusinessWire, April 20, 2010
- OVP Leads Investment in Aggregate Knowledge - TechFlash, January 6, 2010
|
|
Portfolio Company News
|
|
Technology that will enable the company to improve the efficacy, safety, dosing, and other characteristics of protein-based therapeutics. Initially focusing on developing enhanced formulations of currently approved protein therapies. Carl Weissman is on the board.
- Allozyne announces Positive Results from Phase 1B Trial of AZ01 - October 18, 2011
- Allozyne Passes First Clinical Trial, Dreams Big about a Once-Monthly MS Drug - Xconomy, January 10, 2011
- Allozyne's Next Drug, Made to Kill Two Birds With One Stone, Being Prepped for Clinic - Xconomy, November 16, 2010
- Allozyne Fortifies Its Proprietary Position - Forbes.com, July 15, 2010
- Allozyne, After a Stealthy Year - Xconomy, July 14, 2010
|
|
Collaborative Software Initiative |
|
Portfolio Company News
|
|
Collaborative Software Initiative: Applying the successful open source software model to essential application development among like-minded IT companies at a fraction of the cost of developing themselves. Gerry Langeler is on the board.
|
|
|
Portfolio Company News
|
|
The company has developed a novel combination of high-density DNA nanoarrays, sequencing-by-hybridization and combinatorial probe-ligation chemistry, and high-performance computing techniques that promise to provide researchers and clinicians with fast, accurate, and inexpensive complete human genome sequencing. Chad Waite is on the board.
- Complete Genomics CEO on DNA Sequencing Capacity - The Washington Post, January 30. 2012
- CGI and Inova: Two Companies, 1,500 Genomes, One Ambitious Fight Against Preterm Births - Singularity Hub, October 6, 2011
- Study (using Complete Genomics) aims to decode baby DNA - FierceBiotech IT, September 12, 2011
- Lessons learned by Complete Genomics' Cliff Reid - San Francisco Business Times, September 9, 2011
- Complete Genomics Prices 5.5M Shares at $12.50 - Forbes.com, May 26, 2011
- Complete Genomics Doing Well in 2011, Thousands More Genomes On Order - Singularity Hub, May 11, 2011
- Complete Genomics Adds 29 High-Coverage, Complete Human Genome Sequencing Datasets to its Public Genome Repository - Yahoo Finance, April 6, 2011
- Complete Genomics Taps DNAnexus' Coud-Based Informatics Solution - Genetic Engineering News, March 14, 2011
- Where robots labour to overcome genetic disease - ChemInfo, March 25, 2011
- Complete Genomics Selected by MIT's Technology Review for Top 50 Innovative Companies, February 22, 2011
|
|
|
Portfolio Company News
|
|
Headquartered in Boise, Idaho, CradlePoint engineers and manufactures cellular routers and software platforms that facilitate secure mobile computing via the 3G and 4G mobile broadband networks. Gerry Langeler is on the board.
- CradlePoint makes important announcement regarding it's product lineup - January 4, 2012
- CradlePoint names Boise venture capitalist as CEO - The Idaho Statesman, September 29, 2011
- Sprint Certification Given to CradlePoint for New 3G and 4G Business Grade Modems - TMCNet, May 3, 2011
- CradlePoint Advances Support for Verizon Wireless 4G LTE Network - February 24, 2011
- Cradlepoint And Sprint to Deliver 4G Network Failover to the Retail Industry Through Alliance With Ingram Micro - Daily Markets, January 10, 2011
- OVP backs Boise's CradlePoint - Techflash, December 14, 2010
|
|
|
Portfolio Company News
|
|
DataSphere, headquartered in Bellevue, WA, is the leading provider of hyperlocal web technologies and sales solutions for media companies. Lucinda Stewart is on the board.
- DataSphere's Cowan On How TV Stations Are Going Hyperlocal Online - Streetfight Magazine, November 10, 2011
- Seattle's Fisher Communications sees big jump in online ad sales - TechFlash, November 7, 2011
- Growth spurt continues at DataSphere - GeekWire, April 18, 2011
- The hyperlocal news effort that's bigger than Patch - lostremote, September 9, 2010
- DataSphere raises $10M from OVP and others, plans to hire 150 - TechFlash, September 9, 2010
|
|
|
Portfolio Company News
|
|
Headquartered in Seattle, Washington, EnerG2 Inc. is an advanced materials company addressing the commercial and technical challenges of energy storage. Our technology is our advantage - rather than accept the limitations of naturally occurring materials, we use our materials science expertise to assemble high performance products at the molecular level. EnerG2 provides materials that have been turned to meet the unique cost and performance requirements of our global customers. Gerry Langeler is on the board.
- EPA Chief comes to Seattle, vows job growth - King5 news, Janaury 25, 2012
- EnerG2 Receives Prestigious Research Project from the Advanced Lead-Acid Battery Consortium - Digital Journal, September 22, 2011
- How Government Should Promote Innovation - Forbes.com, June 3, 2011
- EnerG2 Moves Into 'Execute Mode' to Enhance Batteries, Natural Gas Cars - Xconomy, April 6, 2011
- UWs Clean Tech Start-Up EnerG2 takes a giant step with "First in the World" manufacturing plant - January 16, 2011
- EnerG2 Kicks off Fed-backed Factory: First ultracaps, then the World - gigaom, August 11, 2010
- EnerG2 video - YouTube, August 13, 2010
- Oregon Frozen-Pea Processor Inspires High-Tech Battery Firm - OPB, August 10, 2010
- EnerG2 commences construction at new facility - earthtimes.org, August 10, 2010
- EnerG2 gets started on Albany energy storage materials plant - Sustainable Business Oregon, August 10, 2010
- Energy Storage and the Demise of Gasoline - greentechmedia, June 7, 2010
- EnerG2 raises new funds, Techflash - April 27, 2010
|
|
|
Portfolio Company News
|
|
Fate Therapeutics was founded by the world’s leading experts in adult stem cell biology to develop and commercialize therapies to control the destiny of cells. Carl Weissman is on the board.
- Fate Therapeutics Names Biotech Vet Bill Rastetter as Chairman, Interim CEO - Xconomy, December 14, 2011
- Fate Therapeutics Strengthens Its iPSC Platform - Digital Journal, November 16, 2011
- Takeda announces investment in Fate Therapeutics - zenopa.com, May 5, 2011
- Fate comes in at #6, in FastCompany's Top Ten in Biotech, Fast Company - February 18, 2011
- Fate Therapeutics charts destiny to world-leading stem cell company - January 16, 2011
- Fate Therapeutics Announces Collaboration with BD (Becton, Dickinson and Company) - Xconomy, October 14, 2010
- Fate Therapeutics Receives Red Herring's North America 100 Award for Advancing Stem Cell Technologies and New Medicines, June 28, 2010
- Fate Therapeutics expands its Stem Cell Empire Into Canada - Xconomy, April 8, 2010
- San Diego Biotech in 2030: A Center for Stem Cells, Genomics, Software, Neuroscience - Xconomy, April 2, 2010
|
|
|
<< Start < Prev 1 2 3 Next > End >>
|
